Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

APREA THERAPEUTICS, INC.

(APRE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

APREA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)

10/15/2021 | 04:33pm EST

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 13, 2021, Johan Christenson, M.D., Ph.D. resigned from the Board of Directors of the Company, effective upon the Company's filing of its Form 10-Q for the third quarter of 2021. Such resignation was not the result of any disagreement with the Company on any matter relating to the operations, policies, or practices of the Company.

© Edgar Online, source Glimpses

All news about APREA THERAPEUTICS, INC.
11/08Aprea Therapeutics Reports Third Quarter 2021 Financial Results and Provides Update on ..
PU
11/08APREA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a..
AQ
11/08Aprea Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months..
CI
11/08Aprea Therapeutics Reports Third Quarter 2021 Financial Results and Provides Update on ..
GL
11/04Aprea Therapeutics to Present Data from Clinical Trials Evaluating Eprenetapopt at 63rd..
GL
11/04Aprea Therapeutics to Present Data from Clinical Trials Evaluating Eprenetapopt at 63rd..
GL
11/04Aprea Therapeutics to Present Data from Clinical Trials Evaluating Eprenetapopt at 63rd..
CI
11/03INSIDER SELL : Aprea Therapeutics
MT
10/15APREA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
10/15Aprea Therapeutics, Inc. Announces Resignation of Johan Christenson from the Board of D..
CI
More news
Analyst Recommendations on APREA THERAPEUTICS, INC.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -37,9 M - -
Net cash 2021 54,1 M - -
P/E ratio 2021 -2,33x
Yield 2021 -
Capitalization 89,1 M 89,1 M -
EV / Sales 2021 -
EV / Sales 2022 -
Nbr of Employees 11
Free-Float 90,2%
Chart APREA THERAPEUTICS, INC.
Duration : Period :
Aprea Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends APREA THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 5
Last Close Price 4,15 $
Average target price 4,00 $
Spread / Average Target -3,61%
EPS Revisions
Managers and Directors
Christian S. Schade Chairman, President & Chief Executive Officer
Scott M. Coiante Chief Financial Officer, Secretary & Senior VP
Eyal C. Attar Chief Medical Officer & Senior Vice President
Lars AbrahmsÚn Chief Scientific Officer & Senior Vice President
Bernd Robert Seizinger Independent Director
Sector and Competitors
1st jan.Capi. (M$)
APREA THERAPEUTICS, INC.-15.65%89
MODERNA, INC.215.53%133 648
LONZA GROUP AG29.85%59 443
IQVIA HOLDINGS INC.46.26%50 064
SEAGEN INC.-3.22%30 994
CELLTRION, INC.-40.39%24 431